About

Andy Burns is the Vice-President of Business Development for the MDI (Metered Dose Inhaler) platform and is a member of the senior leadership team of Kindeva. He has been with the company since its inception in 2020 and is responsible for transitioning the current portfolio of MDI products to the more sustainable and lower-GWP alternatives that will be entering the market over the coming years. Before joining Kindeva, he spent 27 years in the Drug Delivery Systems Division of 3M, where he held various positions, including Process and Optimisation Operations Engineer and Business Unit Manager for the Conventional Dosage Platform. Mr Burns holds a bachelor’s degree in Manufacturing Engineering and Management from Loughborough University.